Associated Papers
Neurodevelopmental Implications Underpinning Hereditary Spastic Paraplegia.
Zhi Y et al.
Cns Neuroscience & Therapeutics, 2025
39932116 (PubMed )
Supplement: CNS-31-e70260-s001.xlsx › SPG2
In Silico Structural Analysis Predicting the Pathogenicity of PLP1 Mutations in Multiple Sclerosis.
Avramouli A et al.
Brain Sciences, 2022
Crystal structure of L-aspartate aminotransferase from Schizosaccharomyces pombe.
Jeong SY et al.
Plos One, 2019
PLP1 Mutations in Patients with Multiple Sclerosis: Identification of a New Mutation and Potential Pathogenicity of the Mutations.
Cloake NC et al.
Journal of Clinical Medicine, 2018
Next Generation Molecular Diagnosis of Hereditary Spastic Paraplegias: An Italian Cross-Sectional Study.
D'Amore A et al.
Frontiers in Neurology, 2018
SPG2 mimicking multiple sclerosis in a family identified using next generation sequencing.
Rubegni A et al.
Journal of the Neurological Sciences, 2017
Conformational change in aspartate aminotransferase on substrate binding induces strain in the catalytic group and enhances catalysis.
Hayashi H et al.
The Journal of Biological Chemistry, 2003
Crystal structures of human mitochondrial branched chain aminotransferase reaction intermediates: ketimine and pyridoxamine phosphate forms.
Yennawar NH et al.
Biochemistry, 2002
The structure of human mitochondrial branched-chain aminotransferase.
Yennawar N et al.
Acta Crystallographica. Section D, Biological Crystallography, 2001
Cocrystallization of a mutant aspartate aminotransferase with a C5-dicarboxylic substrate analog: structural comparison with the enzyme-C4-dicarboxylic analog complex.
Oue S et al.
Journal of Biochemistry, 2000
Select a paper to view details